Nocturnal hemodialysis: dialysis for the new millennium

Pierratos, Andreas
November 1999
CMAJ: Canadian Medical Association Journal;11/02/99, Vol. 161 Issue 9, p1137
Academic Journal
Focuses on nocturnal hemodialysis. Benefits of the technology for patients who require kidney dialysis 3 times a week; How the equipment works; Problems encountered in patients such as catheter infections.


Related Articles

  • High-volume online haemodiafiltration: the gold standard in thrice-weekly dialysis. Mitra, Sandip // Journal of Renal Nursing;May2013, Vol. 5 Issue 3, p142 

    The article focuses on online haemodiafiltration (OL-HDF) dialysis technique, and examines its benefits in the improvement of dialysis patient results. It presents a comparison of high-flux haemodialysis (HD) and high-volume OL-HDF, and cites the Dialysis Outcomes and Practice Patterns Study's...

  • When a vascular access site complicates care. Alt, Darrell; Balduf, Robert; Thompson, Elizabeth // RN;Oct86, Vol. 49 Issue 10, p36 

    Offers guidelines for nurses about fistulas and hemodialysis catheters. Information on the access site on the vascular system of the patients; Case example; Description of a synthetic graft access site. INSET: Assessing fistulas, grafts, and shunts.

  • Implantable valve advances blood access. Lewis, John // Design News;3/6/2000, Vol. 56 Issue 5, p148 

    Presents information on Life Site Hemodialysis Access System, an implantable catheter developed by Vasca Inc. for hemodialysis of patients suffering from renal disease. Use of fistula needles in the catheter; Engineering challenges.

  • Cleansing Agents Used for Hemodialysis Catheter Care. Dinwiddie, Lesley C. // Nephrology Nursing Journal;Dec2002, Vol. 29 Issue 6, p599 

    Answers an inquiry on the cleansing agents used for hemodialysis catheter care. Move of the U.S. Centers for Disease Control and Prevention to update its guidelines for the prevention of catheter-related infections; Povidone-iodine as the most widely used cleansing agent of catheters; Data...

  • Dialysis in a suitcase may be coming.  // Cortlandt Forum;4/25/2004, Vol. 17 Issue 4, p22 

    Reports that HomeDialysis Plus, an Oregon company, is building a portable blood-filtering machine to be used for hemodialysis. Design of the machine to shrink dialysis units to the size of a carry-on suitcase; Remarks of CEO Michael Baker on the microtechnology used in building the machine;...

  • A device and a method for rapid and accurate measurement of access recirculation during hemodialysis. Lindsay, Robert M.; Burbank, Jeff; Brugger, James; Bradfield, Edward; Kram, Richard; Malek, Phyllis; Blake, Peter G. // Kidney International;Apr1996, Vol. 49 Issue 4, p1152 

    The article discusses the method and instrument for the measurement of access recirculation during hemodialysis. The method utilizes the hemodynamic recirculation monitor (HDM) which is a noninvasive electronic device employing the magnetic principle in measuring differential conductivity...

  • Forty Years of Vascular Access. Ball, Lynda K. // Nephrology Nursing Journal;Mar/Apr2009, Vol. 36 Issue 2, p119 

    March 9, 1960, was a milestone marker in end stage renal disease history - the date when a patient received the very first arteriovenous Scribner shunt. This began the era of maintenance or chronic hemodialysis. With long-term dialysis a reality, various new types of vascular access were...

  • Two new concepts that might lead to a wearable artificial kidney. Blackshear, Jr., Perry L. // Kidney International Supplement;Jun1978, Issue 8, pS-133 

    A wearable artificial kidney involving two novel components is proposed. It consists of a turbulent flow ultrafiltering shunt, which supplies 20 liters of ultrafiltrate per day to a disposable activated charcoal cartridge (where creatinine, uric acid, and other tightly bound solutes are...

  • Bacteria Beware: ExThera Medical Blood Filter Earns High Marks in Study.  // Medical Product Outsourcing;Apr2015, Vol. 13 Issue 3, p12 

    The article presents a study published in the online journal "PLOS ONE," which showed that the Seraph Microbind Affinity blood filter from ExThera Medical Corp. can eliminate the blood-resistant bacteria, Escherichia coli (E. coli) and Klebsiella pneumonia. Also cited are the annual cases of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics